Sunshine Biopharma Inc.

0.06 USD
+0.00 (+1.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sunshine Biopharma Inc. stock is down -78.23% since 30 days ago. The next earnings date is Apr 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 14 March’s closed higher than February.

About Sunshine Biopharma Inc.

Sunshine Biopharma focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement.